A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015

In 1998, the American Cancer Society (ACS) set a challenge goal for the nation to reduce cancer incidence by 25% over the period between 1992 and 2015. This report examines the trends in cancer incidence between 1992 and 2004. Trends were calculated using data on incident malignant cancer cases from the Surveillance, Epidemiology, and End Results (SEER) Registry. Delay‐adjusted incidence trends for all cancer sites; all cancer sites without prostate cancer included; all cancer sites stratified by gender, age, and race; and for 20 selected cancer sites are presented. Over the first half of the ACS challenge period, overall cancer incidence rates have declined by about 0.6% per year. The greatest overall declines were observed among men and among those aged 65 years and older. The pace of incidence reduction over the first half of the ACS challenge period was only half that necessary to put us on target to achieve the 25% cancer incidence reduction goal in 2015. New understandings of preventable factors are needed, and new efforts are also needed to better act on our current knowledge about how we can prevent cancer, especially by continuing to reduce tobacco use and beginning to reverse the epidemic of obesity.

[1]  J. Manson,et al.  Estrogen therapy and coronary-artery calcification. , 2007, The New England journal of medicine.

[2]  Michael J Thun,et al.  Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women , 2007, Breast Cancer Research.

[3]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[4]  Stephanie Daignault,et al.  Rising incidence of small renal masses: a need to reassess treatment effect. , 2007, Journal of the National Cancer Institute.

[5]  E. Gilpin,et al.  The California Tobacco Control Program’s effect on adult smokers: (2) Daily cigarette consumption levels , 2007, Tobacco Control.

[6]  Ugo Pastorino,et al.  Computed tomography screening and lung cancer outcomes. , 2007, JAMA.

[7]  N. Rothman,et al.  Polychlorinated Biphenyls and Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  Martyn T. Smith,et al.  Benzene Exposure and Risk of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[9]  P. Hartge,et al.  Environmental and Behavioral Factors and the Risk of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[10]  D. Ross Predicting Thyroid Malignancy , 2006 .

[11]  M. Lübbert,et al.  Acute Myeloid Leukemia: Epidemiology and Etiology , 2006, Cancer.

[12]  O. Miettinen,et al.  Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .

[13]  M. Aickin,et al.  Mammography screening rates decline: a person-time approach to evaluation. , 2006, Preventive medicine.

[14]  M. Weinstock,et al.  Trends in Sunburns, Sun Protection Practices, and Attitudes Toward Sun Exposure Protection and Tanning Among US Adolescents, 1998–2004 , 2006, Pediatrics.

[15]  Roger Williams Global challenges in liver disease , 2006, Hepatology.

[16]  J. Potter,et al.  Risks and benefits of celecoxib to prevent recurrent adenomas. , 2006, The New England journal of medicine.

[17]  Colin W Shepard,et al.  Hepatitis B virus infection: epidemiology and vaccination. , 2006, Epidemiologic reviews.

[18]  R. Hiatt,et al.  Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979-2003. , 2006, International journal of epidemiology.

[19]  Tim Byers,et al.  A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015 , 2006, Cancer.

[20]  C. Wheeler,et al.  Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. , 2006, Vaccine.

[21]  M. Thun,et al.  Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women , 2006, Cancer.

[22]  H. El‐Serag,et al.  The epidemiology of pancreatic cancer in the United States: changes below the surface , 2006, Alimentary pharmacology & therapeutics.

[23]  J. Hoofnagle,et al.  Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity , 2006, Oncogene.

[24]  Norman Wolmark,et al.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.

[25]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[26]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[27]  A. Chokkalingam,et al.  Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.

[28]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[29]  R. Dobson US cigarette consumption falls to lowest point since 1951 , 2006, BMJ : British Medical Journal.

[30]  J. Herman,et al.  Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. , 2006, Cancer research.

[31]  K. Ekström-Smedby,et al.  Epidemiology and etiology of non-Hodgkin lymphoma – a review , 2006, Acta oncologica.

[32]  Liang Cheng,et al.  Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.

[33]  James L Mulshine,et al.  Lung cancer screening. , 2005, The oncologist.

[34]  Anthony J Alberg,et al.  Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Michael M Lieber,et al.  Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2005, Journal of the National Cancer Institute.

[36]  R. Kaaks,et al.  Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  William D Mosher,et al.  Use of contraception and use of family planning services in the United States: 1982-2002. , 2004, Advance data.

[38]  D. Miglioretti,et al.  Hormone Therapy Prescribing Patterns in the United States , 2004, Obstetrics and gynecology.

[39]  R. Stafford,et al.  National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. , 2004, Archives of internal medicine.

[40]  Hong Nguyen,et al.  Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. , 2004, Archives of pathology & laboratory medicine.

[41]  Linda Humphrey,et al.  Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.

[42]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[43]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[44]  R. Stafford,et al.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence. , 2004, JAMA.

[45]  K. McGlynn,et al.  The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.

[46]  T. Byers,et al.  Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  Michael M Lieber,et al.  Journal Review , 2003, International Society of Hair Restoration Surgery.

[48]  G. Beck,et al.  A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.

[49]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[50]  D. Roder,et al.  The epidemiology of gastric cancer , 2002, Gastric Cancer.

[51]  G. Giovino Epidemiology of tobacco use in the United States , 2002, Oncogene.

[52]  E. Feuer,et al.  Impact of reporting delay and reporting error on cancer incidence rates and trends. , 2002, Journal of the National Cancer Institute.

[53]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[54]  M. Berger,et al.  Epidemiology of primary brain tumors: current concepts and review of the literature. , 2002, Neuro-oncology.

[55]  Ailsa E Gebbie,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333 , 2002, Journal of Family Planning and Reproductive Health Care.

[56]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[57]  Michael Pignone,et al.  Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[58]  Patrick C. Walsh,et al.  American Cancer Society guidelines for the early detection of cancer. , 2002, CA: a cancer journal for clinicians.

[59]  V. Moreno,et al.  Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995 , 2002, International journal of cancer.

[60]  L. Brown,et al.  Epidemiologic trends in esophageal and gastric cancer in the United States. , 2002, Surgical oncology clinics of North America.

[61]  Agathe Guilloux,et al.  Incidence and mortality from stomach cancer in Japan, Slovenia and the USA , 2002, International journal of cancer.

[62]  Harry J de Koning,et al.  Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial , 2002, International journal of cancer.

[63]  A. Jemal,et al.  Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.

[64]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[65]  J. Gohagan,et al.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. , 2000, Controlled clinical trials.

[66]  B Järvholm,et al.  Obesity, hypertension, and the risk of kidney cancer in men. , 2000, The New England journal of medicine.

[67]  J. Wong,et al.  Estimating future hepatitis C morbidity, mortality, and costs in the United States. , 2000, American journal of public health.

[68]  Daniel S. Miller,et al.  The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.

[69]  V. Siskind,et al.  Beyond ovulation: oral contraceptives and epithelial ovarian cancer. , 2000, Epidemiology.

[70]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[71]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[72]  N. Muñoz,et al.  Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women , 1999, International journal of cancer.

[73]  Daniel S. Miller,et al.  Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.

[74]  E. Gold,et al.  Epidemiology of and risk factors for pancreatic cancer. , 1995, The Surgical clinics of North America.

[75]  B A Miller,et al.  The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.

[76]  K. Kerlikowske,et al.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis. , 1995, Obstetrics and gynecology.

[77]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[78]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[79]  E. Mazzaferri,et al.  Increasing Incidence of Thyroid Cancer in the United States, 1973–2002Davies L, Welch HG (Dept of Veterans Affairs Med Ctr, White River Junction, Vt; Darmouth Med School, Hanover, NH) JAMA 295:2164–2167, 2006§ , 2007 .

[80]  Karin Ekstrom-Smedby,et al.  Epidemiology and etiology of non-Hodgkin lymphoma – a review , 2006 .

[81]  N. Rhodus Oral cancer: leukoplakia and squamous cell carcinoma. , 2005, Dental clinics of North America.

[82]  María Elena Martínez,et al.  Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[83]  R. Cartwright,et al.  Epidemiology of Multiple Myeloma. , 1998, Hematology.

[84]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[85]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[86]  L. G. Koss,et al.  Cervical Cancer , 1981, Current Topics in Pathology.

[87]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.